Bayer: 5 key drugs to have combined peak sales of 5.5 billion euro Reuters via Yahoo! Canada News Wed, 14 Nov 2012 01:47 AM PST LEVERKUSEN, Germany (Reuters) - Bayer said its five most promising new drugs have an annual peak sales potential of more than 5.5 billion euros ($7 billion). The sales forecast comprises anti-clotting pill Xarelto, ophthalmic drug Eylea, also calle VEGF Trap-Eye, anti-cancer products Alpharadin and Stivarga, as well as lung treatment riociguat. Last year, Bayer said four of the drugs, excluding ... | | |
|
No comments:
Post a Comment